resources

Sun Pharmaceutical Industries Ltd.

NSE: SUNPHARMA

BSE: 524715

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

1,922.40+51.4 (+2.75%)

3 Jul, 11:30 AM

Overview Analysis Statements Technicals Forecast Peers Resources

News

Annual Reports and Financial Documents

Sun Pharmaceutical Industries Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
Annual Reports	FY 2013	FY 2014	FY 2015	FY 2016	FY 2017	FY 2018	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	—
Quarterly Results	—	—	—	—	—	—	Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar
Conference Calls	—	—	—	—	—	—	—	—	2Jun 6Aug 11Nov	3Feb 2Jun 3Aug 5Nov	1Feb 31May 9Aug 8Nov	29May 7Aug 4Nov	6Feb 29May 6Aug 11Nov	4Feb 5May 29May
Presentations	—	—	—	—	—	—	—	—	—	24Mar 16Sept	16Jan 28Apr 21Jul 11Sept	14Mar 10Jul 30Sept 28Nov	4Mar 14Jul 1Sept 26Dec	24Feb 27Apr

Corporate Announcements and Regulatory Filings

Sun Pharmaceutical Industries Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.

Newspaper Publication26 Jun 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Advertisement
Closure of Trading Window25 Jun 2026
Closure of Trading Window
Closure of trading window
Acquisition20 Jun 2026
Announcement under Regulation 30 (LODR)-Acquisition
Acquisition of Innovcare Lifesciences Private Limited
Newspaper Publication16 Jun 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Information about transfer of equity shares and unclaimed dividends to the Investor Education and Protection Fund (IEPF) Account
General14 Jun 2026
Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015
As attached
Record Date12 Jun 2026
Intimation Of Record Date For The Purpose Of Final Dividend For FY 2025-26
Intimation of Record Date
Dividend11 Jun 2026
Corporate Action-Board to consider Dividend
Intimation of Record Date for Final Dividend
General11 Jun 2026
Intimation Of 34Th Annual General Meeting And Record Date For Final Dividend And Connected Matters
Intimation of 34th AGM and Record Date for Final Dividend
Analyst / Investor Meet27 May 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst/Institutional Investor Meeting
General26 May 2026
Filing Of Application For Reclassification With Stock Exchanges
Filing of Application for reclassification with stock exchanges
Press Release / Media Release26 May 2026
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release
Analyst / Investor Meet25 May 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst/Institutional Investor Meeting
Newspaper Publication23 May 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication for financial results for the year ended 31 March 2026
General22 May 2026
Investor Call Audio Recording
Q4FY26 Investor Call Audio Recording
General22 May 2026
Additional Outcome Of The Board Meeting
Additional Outcome of the Board Meeting held today i.e., 22 May 2026
Outcome of Board Meeting22 May 2026
Board Meeting Outcome for Recommendation Of Final Dividend
Recommendation of Final Dividend
Newspaper Publication20 May 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Intimation of Newspaper publication for special window for transfer of physical shares
General14 May 2026
Intimation For Receipt Of Requests For Reclassification Of Shareholder Category
Intimation for receipt of request for reclassification of shareholders category
Analyst / Investor Meet13 May 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Earnings call for the financial results of the fourth quarter on 22 May 2026
Change in Directorate12 May 2026
Announcement under Regulation 30 (LODR)-Change in Directorate
Change in Board of Directors and Composition of Committees

Frequently Asked Questions

Where can I download the annual report of Sun Pharmaceutical Industries Ltd.?

Annual reports of Sun Pharmaceutical Industries Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.

Where can I find the quarterly results of Sun Pharmaceutical Industries Ltd.?

Quarterly earnings results and presentations of Sun Pharmaceutical Industries Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.

Does Sun Pharmaceutical Industries Ltd. publish earnings call transcripts?

Earnings call transcripts of Sun Pharmaceutical Industries Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.

Where can I find investor presentations of Sun Pharmaceutical Industries Ltd.?

Investor presentations and annual day presentations of Sun Pharmaceutical Industries Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.

What are the recent corporate announcements of Sun Pharmaceutical Industries Ltd.?

Corporate announcements and regulatory filings of Sun Pharmaceutical Industries Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.

How do I access the regulatory filings of Sun Pharmaceutical Industries Ltd.?

Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Sun Pharmaceutical Industries Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.

What is the ISIN of Sun Pharmaceutical Industries Ltd.?

The ISIN (International Securities Identification Number) of Sun Pharmaceutical Industries Ltd. is INE044A01036. This is the unique identifier used across exchanges and depositories.

On which stock exchange is Sun Pharmaceutical Industries Ltd. listed?

Sun Pharmaceutical Industries Ltd. is listed on NSE and BSE. The NSE symbol is SUNPHARMA and the BSE code is -.

Where can I find the shareholding pattern of Sun Pharmaceutical Industries Ltd.?

The quarterly shareholding pattern of Sun Pharmaceutical Industries Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.

How current is the data for Sun Pharmaceutical Industries Ltd. on Sharpely?

Share price data for Sun Pharmaceutical Industries Ltd. is updated as of 3 Jul 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.